Myeloid Dysplasia
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche (NCT05520749) | Fondazione Italiana Sindromi Mielodisplastiche-ETS | 2022-01-01 |
| Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors (NCT06785077) | European Institute of Oncology | 2020-10-02 |
Track Myeloid Dysplasia automatically
Every clearance here is in the API, with alerts when new ones post.